Reaction
Ovarian Hyperstimulation Syndrome reporting signals
As of the last recalculation, Ovarian Hyperstimulation Syndrome appears in 2,310 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is PROGESTERONE (PRR 161.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Progesterone | 348 | 161.3 | 163.8 |
| Letrozole Tablets | 129 | 25.5 | 25.6 |
| Letrozole | 157 | 24.6 | 24.6 |
| Sodium Chloride Tablet | 113 | 14.5 | 14.5 |
| Sodium Chloride Tablets | 113 | 14.5 | 14.5 |
| Sodium Chloride | 113 | 13.5 | 13.5 |
| Estradiol Gel 0.1% | 59 | 12.0 | 12.1 |
| Estradiol Transdermal | 59 | 12.0 | 12.1 |
| Dalteparin Sodium | 14 | 12.0 | 12.0 |
| Goserelin | 17 | 11.5 | 11.5 |
| Estradiol | 74 | 7.9 | 7.9 |
| Enoxaparin Sodium | 48 | 7.7 | 7.7 |
| Leuprolide Acetate | 50 | 5.9 | 5.9 |
| Relugolix | 5 | 1.9 | 1.9 |